FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

John Cheville

Research Profile

Disorders

Procedures

Concepts & Ideas

Chemicals & Drugs

Biological Tumor Markers

Physiology

Co-author Network

Publications

TOP 3
Brian J Linder; Robert F Tarrell; Prabin Thapa; R Houston Thompson; Matthew K Tollefson; John C Cheville; Igor Frank; Stephen A Boorjian
The impact of perioperative blood transfusion on cancer recurrence and survival following radical cystectomy.
Brian J Linder; Robert F Tarrell; Prabin Thapa; R Houston Thompson; John C Cheville; Igor Frank; Stephen A Boorjian
Outcomes following radical cystectomy for nested variant of urothelial carcinoma: a matched cohort analysis.
Ryan E Swapp; Diva R Salomão; Marie Christine Aubry; John C Cheville
Outside case review of surgical pathology for referred patients: the impact on patient care.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of John Cheville (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Brian J Linder; Robert F Tarrell; Prabin Thapa; R Houston Thompson; Matthew K Tollefson; John C Cheville; Igor Frank; Stephen A Boorjian
The impact of perioperative blood transfusion on cancer recurrence and survival following radical cystectomy.
European urology 2013;63(5):839-45.
2013: Brian J Linder; Robert F Tarrell; Prabin Thapa; R Houston Thompson; John C Cheville; Igor Frank; Stephen A Boorjian
Outcomes following radical cystectomy for nested variant of urothelial carcinoma: a matched cohort analysis.
The Journal of urology 2013;189(5):1670-5.
2013: Ryan E Swapp; Diva R Salomão; Marie Christine Aubry; John C Cheville
Outside case review of surgical pathology for referred patients: the impact on patient care.
Archives of pathology & laboratory medicine 2013;137(2):233-40.
2012: Jeffrey K Wang; Stephen A Boorjian; John C Cheville; Simon P Kim; Robert F Tarrell; Prabin Thapa; Igor Frank
Outcomes following radical cystectomy for micropapillary bladder cancer versus pure urothelial carcinoma: a matched cohort analysis.
World journal of urology 2012;30(6):801-6.
2012: Shabnam Zarei; Stephen A Boorjian; Igor Frank; Simon Kim; Robert Tarrell; Prabin Thapa; R Houston Thompson; Christopher Weight; John C Cheville
Prognostic significance of measured depth of invasion of urothelial carcinoma of the bladder compared to the 2010 American Joint Committee on Cancer pT2 and pT3 classifications.
The Journal of urology 2012;188(5):1706-11.
2012: William R Sukov; R Houston Thompson; Monica K Akre; Jennelle C Hodge; Bradley C Leibovich; Christine M Lohse; John C Cheville
ALK alterations in adult renal cell carcinoma: frequency, clinicopathologic features and outcome in a large series of consecutively treated patients.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2012;25(11):1516-25.
2012: John J Knoedler; Robert F Tarrell; Prabin Thapa; Christopher J Weight; Stephen A Boorjian; John C Cheville; Simon P Kim; Igor Frank
Does partial cystectomy compromise oncologic outcomes for patients with bladder cancer compared to radical cystectomy? A matched case-control analysis.
The Journal of urology 2012;188(4):1115-9.
2012: Jacob Jorns; Bradley C Leibovich; Christine M Lohse; Michelle L Arnold; John C Cheville; David D Thiel; Adrienne Williams; Alexander S Parker
Three-dimensional tumour volume and cancer-specific survival for patients undergoing nephrectomy to treat pT1 clear-cell renal cell carcinoma.
BJU international 2012;110(7):956-60.
2012: Simon P Kim; Prabin Thapa; R Houston Thompson; Christopher J Weight; John C Cheville; Igor Frank; Stephen A Boorjian
The impact of squamous and glandular differentiation on survival after radical cystectomy for urothelial carcinoma.
The Journal of urology 2012;188(2):405-9.
2012: David D Thiel; Michelle L Arnold; John C Cheville; Bradley C Leibovich; Christine M Lohse; Alexander S Parker
Does left side renal cell carcinoma (RCC) with renal vein/vena cava thrombus predict worse prognosis than equivalent right side RCC tumor thrombus?
International urology and nephrology 2012;44(4):1005-12.
2012: Christopher J Weight; Eric J Bergstralh; John C Cheville; R Jeffrey Karnes; Simon P Kim; Bradley C Leibovich
A prospective, controlled phase II study of neoadjuvant exisulind therapy before radical prostatectomy: effect on apoptosis.
Urology 2012;80(2):484.e17-22.
2012: Farhad Kosari; Alexey A Leontovich; Stephen J Murphy; Erika Rodriguez; Thomas J Sebo; John C Cheville; Sibel Erdogan; Cristiane M Ida; R Jeffrey Karnes; George Vasmatzis
Shared gene expression alterations in prostate cancer and histologically benign prostate from patients with prostate cancer.
The American journal of pathology 2012;181(1):34-42.
2011: Stephen A Boorjian; John C Cheville; Simon P Kim; Prabin Thapa; Christopher J Weight; Igor Frank
Risk factors and outcomes of urethral recurrence following radical cystectomy.
European urology 2011;60(6):1266-72.
2011: Stephen A Boorjian; John C Cheville; Brian A Costello; Prabin Thapa; Matthew K Tollefson; Igor Frank
Detection of asymptomatic recurrence during routine oncological followup after radical cystectomy is associated with improved patient survival.
The Journal of urology 2011;186(5):1796-802.
2011: Simon P Kim; Bradley C Leibovich; Christine M Lohse; R Houston Thompson; Christopher J Weight; John C Cheville; Brian A Costello; Stephen A Boorjian
Outcomes and clinicopathologic variables associated with late recurrence after nephrectomy for localized renal cell carcinoma.
Urology 2011;78(5):1101-6.
2011: Saswati Mahapatra; Donald J Tindall; Charles Y F Young; John C Cheville; Michael W Holmes; R Jeffrey Karnes; Eric W Klee; Manish Kohli; Krishna Vanaja Donkena
Novel molecular targets of Azadirachta indica associated with inhibition of tumor growth in prostate cancer.
The AAPS journal 2011;13(3):365-77.
2011: M Adam Childs; Michael L Blute; Rodney H Breau; John C Cheville; Christine M Lohse; R Houston Thompson; Eric C Umbreit; Bradley C Leibovich
Metachronous renal tumours after surgical management of oncocytoma.
BJU international 2011;108(6):816-9.
2011: Simon P Kim; Angela L Alt; Christopher J Weight; Brian A Costello; John C Cheville; CM Lohse; Cristine Allmer; Bradley C Leibovich
Independent validation of the 2010 American Joint Committee on Cancer TNM classification for renal cell carcinoma: results from a large, single institution cohort.
The Journal of urology 2011;185(6):2035-9.
2011: Paul L Crispen; Rodney H Breau; Cristine Allmer; Christine M Lohse; John C Cheville; Bradley C Leibovich; Michael L Blute
Lymph node dissection at the time of radical nephrectomy for high-risk clear cell renal cell carcinoma: indications and recommendations for surgical templates.
European urology 2011;59(1):18-23.
2010: R Jeffrey Karnes; John C Cheville; Cristiane M Ida; Thomas J Sebo; Asha A Nair; Hui Tang; Jan-Marie Munz; Farhad Kosari; George Vasmatzis
The ability of biomarkers to predict systemic progression in men with high-risk prostate cancer treated surgically is dependent on ERG status.
Cancer research 2010;70(22):8994-9002.
2010: Paul L Crispen; Mitra R Tabidian; Cristine Allmer; Christine M Lohse; Rodney H Breau; Michael L Blute; John C Cheville; Bradley C Leibovich
Unclassified renal cell carcinoma: impact on survival following nephrectomy.
Urology 2010;76(3):580-6.
2010: Bradley C Leibovich; Christine M Lohse; Paul L Crispen; Stephen A Boorjian; R Houston Thompson; Michael L Blute; John C Cheville
Histological subtype is an independent predictor of outcome for patients with renal cell carcinoma.
The Journal of urology 2010;183(4):1309-15.
2010: Jian Yuan; Kuntian Luo; Lizhi Zhang; John C Cheville; Zhenkun Lou
USP10 regulates p53 localization and stability by deubiquitinating p53.
Cell 2010;140(3):384-96.
2010: William R Sukov; John C Cheville; Caterina Giannini; Austin W Carlson; Brandon M Shearer; Jason P Sinnwell; Rhett P Ketterling
Isochromosome 12p and polysomy 12 in primary central nervous system germ cell tumors: frequency and association with clinicopathologic features.
Human pathology 2010;41(2):232-8.
2010: Robert P Myers; John C Cheville; Wojciech Pawlina
Making anatomic terminology of the prostate and contiguous structures clinically useful: historical review and suggestions for revision in the 21st century.
Clinical anatomy (New York, N.Y.) 2010;23(1):18-29.
2009: Rodney H Breau; John C Cheville; Christine M Lohse; Eugene D Kwon; Michael L Blute
Re: Presence of tumor necrosis is not a significant predictor of survival in clear cell renal cell carcinoma: higher prognostic accuracy of extent based rather than presence/absence classification. T. Klatte, J. W. Said, M. de Martino, J. Larochelle, B. Shuch, J. Y. Rao, G. V. Thomas, F. F. Kabbinavar, A. S. Belldegrun and A. J. Pantuck. J Urol 2009; 181: 1558-1564.
The Journal of urology 2009;182(6):2979-80; author reply 2980-1.
2009: Christian A Hettinger; John C Cheville; Aida N Lteif; Nathan A Bradley; Stephen A Kramer
Precocious puberty in a 7-year-old boy: a novel case.
Journal of pediatric urology 2009;5(5):412-4.
2009: William R Sukov; Rhett P Ketterling; Donna J Lager; Austin W Carlson; Jason P Sinnwell; George K Chow; Robert B Jenkins; John C Cheville
CCND1 rearrangements and cyclin D1 overexpression in renal oncocytomas: frequency, clinicopathologic features, and utility in differentiation from chromophobe renal cell carcinoma.
Human pathology 2009;40(9):1296-303.
2009: Sameer A Siddiqui; Igor Frank; John C Cheville; Christine M Lohse; Bradley C Leibovich; Michael L Blute
Postoperative surveillance for renal cell carcinoma: a multifactorial histological subtype specific protocol.
BJU international 2009;104(6):778-85.
2009: Donkena Krishna Vanaja; Mathias Ehrich; Dirk van den Boom; John C Cheville; R Jeffrey Karnes; Donald J Tindall; Charles R Cantor; Charles Y F Young
Hypermethylation of genes for diagnosis and risk stratification of prostate cancer.
Cancer investigation 2009;27(5):549-60.
2009: Donkena Krishna Vanaja; Michael E Grossmann; John C Cheville; Mozammel H Gazi; Aiyu Gong; Jin San Zhang; Katalin Ajtai; Thomas P Burghardt; Charles Y F Young
PDLIM4, an actin binding protein, suppresses prostate cancer cell growth.
Cancer investigation 2009;27(3):264-72.
2009: William R Sukov; John C Cheville; Mahul B Amin; Ruta Gupta; Andrew L Folpe
Perivascular epithelioid cell tumor (PEComa) of the urinary bladder: report of 3 cases and review of the literature.
The American journal of surgical pathology 2009;33(2):304-8.
2008: Paul L Crispen; Stephen A Boorjian; Christine M Lohse; Thomas S Sebo; John C Cheville; Michael L Blute; Bradley C Leibovich
Outcomes following partial nephrectomy by tumor size.
The Journal of urology 2008;180(5):1912-7.
2008: John C Cheville; R Jeffrey Karnes; Terry M Therneau; Farhad Kosari; Jan-Marie Munz; Lori Tillmans; Eati Basal; Laureano J Rangel; Erik J Bergstralh; Irina V Kovtun; C D Savci-Heijink; Eric W Klee; George Vasmatzis
Gene panel model predictive of outcome in men at high-risk of systemic progression and death from prostate cancer after radical retropubic prostatectomy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(24):3930-6.
2008: Wade G Alleman; Brian Gorman; Bernard F King; Dirk R Larson; John C Cheville; Ajay Nehra
Benign and malignant epididymal masses evaluated with scrotal sonography: clinical and pathologic review of 85 patients.
Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine 2008;27(8):1195-202.
2008: Alexander S Parker; Christine M Lohse; Bradley C Leibovich; John C Cheville; Yuri M Sheinin; Eugene D Kwon
Comparison of digital image analysis versus visual assessment to assess survivin expression as an independent predictor of survival for patients with clear cell renal cell carcinoma.
Human pathology 2008;39(8):1176-84.
2008: Candace F Granberg; Stephen A Boorjian; Hartzell V Schaff; Thomas A Orszulak; Bradley C Leibovich; Christine M Lohse; John C Cheville; Michael L Blute
Surgical management, complications, and outcome of radical nephrectomy with inferior vena cava tumor thrombectomy facilitated by vascular bypass.
Urology 2008;72(1):148-52.
2008: Masahiro Yanagisawa; Deborah Huveldt; Pamela Kreinest; Christine M Lohse; John C Cheville; Alexander S Parker; John A Copland; PZ Anastasiadis
A p120 catenin isoform switch affects Rho activity, induces tumor cell invasion, and predicts metastatic disease.
The Journal of biological chemistry 2008;283(26):18344-54.
2008: Amy Krambeck; Markian Iwaszko; Bradley C Leibovich; John C Cheville; Igor Frank; Michael Blute
Long-term outcome of multiple ipsilateral renal tumours found at the time of planned nephron-sparing surgery.
BJU international 2008;101(11):1375-9.
2008: Alexander Parker; Christine Lohse; John C Cheville; Bradley C Leibovich; Todd Igel; Michael Blute
Evaluation of the association of current cigarette smoking and outcome for patients with clear cell renal cell carcinoma.
International journal of urology : official journal of the Japanese Urological Association 2008;15(4):304-8.
2008: Farhad Kosari; Jan Marie A Munz; C Dilara Savci-Heijink; Craig Spiro; Eric W Klee; Dagmar M Kube; Lori Tillmans; Jeff Slezak; R Jeffrey Karnes; John C Cheville; George Vasmatzis
Identification of prognostic biomarkers for prostate cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(6):1734-43.
2008: James S Magera; Igor Frank; Christine M Lohse; Bradley C Leibovich; John C Cheville; Michael L Blute
Analysis of repeat nephron sparing surgery as a treatment option in patients with a solid mass in a renal remnant.
The Journal of urology 2008;179(3):853-6.
2008: James S Magera; Bradley C Leibovich; Christine M Lohse; Shomik Sengupta; John C Cheville; Eugene D Kwon; Michael L Blute
Association of abnormal preoperative laboratory values with survival after radical nephrectomy for clinically confined clear cell renal cell carcinoma.
Urology 2008;71(2):278-82.
2008: R Houston Thompson; Stephen A Boorjian; Christine M Lohse; Bradley C Leibovich; Eugene D Kwon; John C Cheville; Michael L Blute
Radical nephrectomy for pT1a renal masses may be associated with decreased overall survival compared with partial nephrectomy.
The Journal of urology 2008;179(2):468-71; discussion 472-3.
2008: Nathan E Hoffmann; Michael D Gillett; John C Cheville; Christine M Lohse; Bradley C Leibovich; Michael L Blute
Differences in organ system of distant metastasis by renal cell carcinoma subtype.
The Journal of urology 2008;179(2):474-7.
2008: Mozammel H Gazi; MeiLan He; John C Cheville; Charles Y F Young
Downregulation of IgG Fc binding protein (Fc gammaBP) in prostate cancer.
Cancer biology & therapy 2008;7(1):70-5.
2007: Stephen A Boorjian; Igor Frank; Brant Inman; Christine M Lohse; John C Cheville; Bradley C Leibovich; Michael L Blute
The role of partial nephrectomy for the management of sporadic renal angiomyolipoma.
Urology 2007;70(6):1064-8.
2007: W Scott Webster; R Houston Thompson; John C Cheville; Christine M Lohse; Michael L Blute; Bradley C Leibovich
Surgical resection provides excellent outcomes for patients with cystic clear cell renal cell carcinoma.
Urology 2007;70(5):900-4; discussion 904.
2007: Bradley C Leibovich; Yuri Sheinin; Christine M Lohse; R Houston Thompson; John C Cheville; Jan Zavada; Eugene D Kwon
Carbonic anhydrase IX is not an independent predictor of outcome for patients with clear cell renal cell carcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(30):4757-64.
2007: David J Schwartz; Shomik Sengupta; David W Hillman; Daniel J Sargent; John C Cheville; Torrence M Wilson; Lance A Mynderse; Richard Choo; Brian J Davis
Prediction of radial distance of extraprostatic extension from pretherapy factors.
International journal of radiation oncology, biology, physics 2007;69(2):411-8.
2007: Timothy J Roth; Yuri Sheinin; Christine M Lohse; Susan M Kuntz; Xavier Frigola; Brant A Inman; Amy E Krambeck; Maureen E McKenney; R Jeffrey Karnes; Michael L Blute; John C Cheville; Thomas J Sebo; Eugene D Kwon
B7-H3 ligand expression by prostate cancer: a novel marker of prognosis and potential target for therapy.
Cancer research 2007;67(16):7893-900.
2007: Matthew K Tollefson; R Houston Thompson; Yuri Sheinin; Christine M Lohse; John C Cheville; Bradley C Leibovich; Eugene D Kwon
Ki-67 and coagulative tumor necrosis are independent predictors of poor outcome for patients with clear cell renal cell carcinoma and not surrogates for each other.
Cancer 2007;110(4):783-90.
2007: R Houston Thompson; Michael L Blute; Amy E Krambeck; Christine M Lohse; James S Magera; Bradley C Leibovich; Eugene D Kwon; Igor Frank; John C Cheville
Patients with pT1 renal cell carcinoma who die from disease after nephrectomy may have unrecognized renal sinus fat invasion.
The American journal of surgical pathology 2007;31(7):1089-93.
2007: William R Sukov; John C Cheville; Austin W Carlson; Brandon M Shearer; Eli J Piatigorsky; Karen L Grogg; Thomas J Sebo; Jason P Sinnwell; Rhett P Ketterling
Utility of ALK-1 protein expression and ALK rearrangements in distinguishing inflammatory myofibroblastic tumor from malignant spindle cell lesions of the urinary bladder.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2007;20(5):592-603.
2007: Sameer A Siddiqui; Xavier Frigola; Sandra Bonne-Annee; Maria Mercader; Susan M Kuntz; Amy E Krambeck; Shomik Sengupta; Haidong Dong; John C Cheville; Christine M Lohse; Christopher J Krco; W Scott Webster; Bradley C Leibovich; Michael L Blute; Keith L Knutson; Eugene D Kwon
Tumor-infiltrating Foxp3-CD4+CD25+ T cells predict poor survival in renal cell carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(7):2075-81.
2007: R Houston Thompson; Haidong Dong; Christine M Lohse; Bradley C Leibovich; Michael L Blute; John C Cheville; Eugene D Kwon
PD-1 is expressed by tumor-infiltrating immune cells and is associated with poor outcome for patients with renal cell carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(6):1757-61.
2007: Amy E Krambeck; Haidong Dong; R Houston Thompson; Susan M Kuntz; Christine M Lohse; Bradley C Leibovich; Michael L Blute; Thomas J Sebo; John C Cheville; Alexander S Parker; Eugene D Kwon
Survivin and b7-h1 are collaborative predictors of survival and represent potential therapeutic targets for patients with renal cell carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(6):1749-56.
2007: Alexander S Parker; Christine M Lohse; Kevin Wu; Pamela A Kreinest; John A Copland; Tracy Hilton; Michael J Wehle; John C Cheville; Michael Blute
Lower expression levels of the transforming growth factor beta receptor type II protein are associated with a less aggressive tumor phenotype and improved survival among patients with clear cell renal cell carcinoma.
Human pathology 2007;38(3):453-61.
2007: Richard A Ashley; Shawn M McGee; Philip A Isotaolo; Stephen A Kramer; John C Cheville
Clinical and pathological features associated with the testicular tumor of the adrenogenital syndrome.
The Journal of urology 2007;177(2):546-9; discussion 549.
2007: R Houston Thompson; Bradley C Leibovich; Christine M Lohse; John C Cheville; Horst Zincke; Michael L Blute; Igor Frank
Dynamic outcome prediction in patients with clear cell renal cell carcinoma treated with radical nephrectomy: the D-SSIGN score.
The Journal of urology 2007;177(2):477-80.
2007: Dagmar M Kube; Cemile D Savci-Heijink; Anne-Francoise Lamblin; Farhad Kosari; George Vasmatzis; John C Cheville; Donald P Connelly; George G Klee
Optimization of laser capture microdissection and RNA amplification for gene expression profiling of prostate cancer.
BMC molecular biology 2007;8():25.
2007: Sameer A Siddiqui; Igor Frank; Bradley C Leibovich; John C Cheville; Christine M Lohse; Horst Zincke; Michael L Blute
Impact of tumor size on the predictive ability of the pT3a primary tumor classification for renal cell carcinoma.
The Journal of urology 2007;177(1):59-62.
2006: Shomik Sengupta; Brian J Davis; Lance A Mynderse; Thomas J Sebo; John C Cheville; Christine M Lohse; David W Hillman; Michael G Haddock; Torrence M Wilson
Permanent prostate brachytherapy: pathologic implications as assessed on radical prostatectomy specimens of broadening selection criteria for monotherapy.
Urology 2006;68(4):810-4.
2006: Alexander S Parker; Christine M Lohse; John C Cheville; David D Thiel; Bradley C Leibovich; Michael L Blute
Greater body mass index is associated with better pathologic features and improved outcome among patients treated surgically for clear cell renal cell carcinoma.
Urology 2006;68(4):741-6.
2006: Sylvain Trahan; Michele Erickson-Johnson; Fausto Rodriguez; Marie-Christine Aubry; John C Cheville; Jeffrey L Myers; Andre M Oliveira
Formation of the 12q14-q15 amplicon precedes the development of a well-differentiated liposarcoma arising from a nonchondroid pulmonary hamartoma.
The American journal of surgical pathology 2006;30(10):1326-9.
2006: Li Zheng; Fengwei Wang; Chiping Qian; Roxann M Neumann; John C Cheville; Donald J Tindall; Wanguo Liu
Unique substitution of CHEK2 and TP53 mutations implicated in primary prostate tumors and cancer cell lines.
Human mutation 2006;27(10):1062-3.
2006: R Houston Thompson; Bradley C Leibovich; John C Cheville; W Scott Webster; Christine M Lohse; Eugene D Kwon; Horst Zincke; Michael L Blute
Second primary malignancies associated with renal cell carcinoma histological subtypes.
The Journal of urology 2006;176(3):900-3; discussion 903-4.
2006: Amy E Krambeck; R Houston Thompson; Haidong Dong; Christine M Lohse; Eugene S Park; Susan M Kuntz; Bradley C Leibovich; Michael L Blute; John C Cheville; Eugene D Kwon
B7-H4 expression in renal cell carcinoma and tumor vasculature: associations with cancer progression and survival.
Proceedings of the National Academy of Sciences of the United States of America 2006;103(27):10391-6.
2006: Shomik Sengupta; John C Cheville; Christine M Lohse; Horst Zincke; Robert P Myers; Darren L Riehle; V Shane Pankratz; Michael L Blute; Thomas J Sebo
Conventional assessment of needle biopsy specimens is more useful than digital image analysis of proliferation and DNA ploidy in prediction of positive surgical margins at radical prostatectomy.
Urology 2006;68(1):94-8.
2006: Alexander S Parker; Farhad Kosari; Christine M Lohse; R Houston Thompson; Eugene D Kwon; Linda Murphy; Darren L Riehle; Michael L Blute; Bradley C Leibovich; George Vasmatzis; John C Cheville
High expression levels of survivin protein independently predict a poor outcome for patients who undergo surgery for clear cell renal cell carcinoma.
Cancer 2006;107(1):37-45.
2006: W Scott Webster; Christine M Lohse; R Houston Thompson; Haidong Dong; Xavier Frigola; Demetrius L Dicks; Shomik Sengupta; Igor Frank; Bradley C Leibovich; Michael L Blute; John C Cheville; Eugene D Kwon
Mononuclear cell infiltration in clear-cell renal cell carcinoma independently predicts patient survival.
Cancer 2006;107(1):46-53.
2006: Shomik Sengupta; Jeffrey M Slezak; Michael L Blute; Bradley C Leibovich; Thomas J Sebo; Robert P Myers; John C Cheville; Erik J Bergstralh; Horst Zincke
Trends in distribution and prognostic significance of Gleason grades on radical retropubic prostatectomy specimens between 1989 and 2001.
Cancer 2006;106(12):2630-5.
2006: R Houston Thompson; Susan M Kuntz; Bradley C Leibovich; Haidong Dong; Christine M Lohse; W Scott Webster; Shomik Sengupta; Igor Frank; Alexander S Parker; Horst Zincke; Michael L Blute; Thomas J Sebo; John C Cheville; Eugene D Kwon
Tumor B7-H1 is associated with poor prognosis in renal cell carcinoma patients with long-term follow-up.
Cancer research 2006;66(7):3381-5.
2006: Donkena Krishna Vanaja; Karla V Ballman; Bruce W Morlan; John C Cheville; Roxann M Neumann; Michael M Lieber; Donald J Tindall; Charles Y F Young
PDLIM4 repression by hypermethylation as a potential biomarker for prostate cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(4):1128-36.
2006: Shomik Sengupta; Christine M Lohse; John C Cheville; Bradley C Leibovich; R Houston Thompson; W Scott Webster; Igor Frank; Horst Zincke; Michael L Blute; Eugene D Kwon
The preoperative erythrocyte sedimentation rate is an independent prognostic factor in renal cell carcinoma.
Cancer 2006;106(2):304-12.
2006: Shomik Sengupta; John C Cheville; Christopher L Corless; Christine M Lohse; Michael C Heinrich; Eugene D Kwon; Horst Zincke; Michael L Blute; Bradley C Leibovich
Rare expression of KIT and absence of KIT mutations in high grade renal cell carcinoma.
The Journal of urology 2006;175(1):53-6.
2005: R Houston Thompson; Michael D Gillett; John C Cheville; Christine M Lohse; Haidong Dong; W Scott Webster; Lieping Chen; Horst Zincke; Michael L Blute; Bradley C Leibovich; Eugene D Kwon
Costimulatory molecule B7-H1 in primary and metastatic clear cell renal cell carcinoma.
Cancer 2005;104(10):2084-91.
2005: Bradley C Leibovich; John C Cheville; Christine M Lohse; Horst Zincke; Igor Frank; Eugene D Kwon; Jaime Merchan; Michael L Blute
A scoring algorithm to predict survival for patients with metastatic clear cell renal cell carcinoma: a stratification tool for prospective clinical trials.
The Journal of urology 2005;174(5):1759-63; discussion 1763.
2005: R Houston Thompson; W Scott Webster; John C Cheville; Christine M Lohse; Haidong Dong; Bradley C Leibovich; Susan M Kuntz; Shomik Sengupta; Eugene D Kwon; Michael L Blute
B7-H1 glycoprotein blockade: a novel strategy to enhance immunotherapy in patients with renal cell carcinoma.
Urology 2005;66(5 Suppl):10-4.
2005: R Houston Thompson; Bradley C Leibovich; John C Cheville; W Scott Webster; Christine M Lohse; Eugene D Kwon; Igor Frank; Horst Zincke; Michael L Blute
Is renal sinus fat invasion the same as perinephric fat invasion for pT3a renal cell carcinoma?
The Journal of urology 2005;174(4 Pt 1):1218-21.
2005: Shomik Sengupta; Christine M Lohse; Bradley C Leibovich; Igor Frank; R Houston Thompson; W Scott Webster; Horst Zincke; Michael L Blute; John C Cheville; Eugene D Kwon
Histologic coagulative tumor necrosis as a prognostic indicator of renal cell carcinoma aggressiveness.
Cancer 2005;104(3):511-20.
2005: Farhad Kosari; Alexander S Parker; Dagmar M Kube; Christine M Lohse; Bradley C Leibovich; Michael L Blute; John C Cheville; George Vasmatzis
Clear cell renal cell carcinoma: gene expression analyses identify a potential signature for tumor aggressiveness.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(14):5128-39.
2005: R Houston Thompson; John C Cheville; Christine M Lohse; W Scott Webster; Horst Zincke; Eugene D Kwon; Igor Frank; Michael L Blute; Bradley C Leibovich
Reclassification of patients with pT3 and pT4 renal cell carcinoma improves prognostic accuracy.
Cancer 2005;104(1):53-60.
2005: Jin-San Zhang; Ai-Yu Gong; John C Cheville; David I Smith; Charles Y F Young
AGR2, an androgen-inducible secretory protein overexpressed in prostate cancer.
Genes, chromosomes & cancer 2005;43(3):249-59.
2005: Alexander S Parker; John C Cheville; Christine M Lohse; Todd C Igel; Bradley C Leibovich; Michael L Blute
Loss of expression of von Hippel-Lindau tumor suppressor protein associated with improved survival in patients with early-stage clear cell renal cell carcinoma.
Urology 2005;65(6):1090-5.
2005: Michael D Gillett; John C Cheville; R Jeffrey Karnes; Christine M Lohse; Eugene D Kwon; Bradley C Leibovich; Horst Zincke; Michael L Blute
Comparison of presentation and outcome for patients 18 to 40 and 60 to 70 years old with solid renal masses.
The Journal of urology 2005;173(6):1893-6.
2005: Igor Frank; Michael L Blute; Bradley C Leibovich; John C Cheville; Christine M Lohse; Horst Zincke
Independent validation of the 2002 American Joint Committee on cancer primary tumor classification for renal cell carcinoma using a large, single institution cohort.
The Journal of urology 2005;173(6):1889-92.
2005: R Houston Thompson; Bradley C Leibovich; John C Cheville; Christine M Lohse; Igor Frank; Eugene D Kwon; Horst Zincke; Michael L Blute
Should direct ipsilateral adrenal invasion from renal cell carcinoma be classified as pT3a?
The Journal of urology 2005;173(3):918-21.
2005: Bradley C Leibovich; John C Cheville; Christine M Lohse; Horst Zincke; Eugene D Kwon; Igor Frank; R Houston Thompson; Michael L Blute
Cancer specific survival for patients with pT3 renal cell carcinoma-can the 2002 primary tumor classification be improved?
The Journal of urology 2005;173(3):716-9.
2005: Ahmad H Bani-Hani; Bradley C Leibovich; Christine M Lohse; John C Cheville; Horst Zincke; Michael L Blute
Associations with contralateral recurrence following nephrectomy for renal cell carcinoma using a cohort of 2,352 patients.
The Journal of urology 2005;173(2):391-4.
2005: Igor Frank; Michael L Blute; Bradley C Leibovich; John C Cheville; Christine M Lohse; Eugene D Kwon; Horst Zincke
pT2 classification for renal cell carcinoma. Can its accuracy be improved?
The Journal of urology 2005;173(2):380-4.
2004: R Houston Thompson; Michael D Gillett; John C Cheville; Christine M Lohse; Haidong Dong; W Scott Webster; Kent G Krejci; John R Lobo; Shomik Sengupta; Lieping Chen; Horst Zincke; Michael L Blute; Scott E Strome; Bradley C Leibovich; Eugene D Kwon
Costimulatory B7-H1 in renal cell carcinoma patients: Indicator of tumor aggressiveness and potential therapeutic target.
Proceedings of the National Academy of Sciences of the United States of America 2004;101(49):17174-9.
2004: Igor Frank; John C Cheville; Michael L Blute; Christine M Lohse; R Jeffrey Karnes; Amy L Weaver; Thomas J Sebo; Ajay Nehra; Horst Zincke
Prognostic value of p53 and MIB-1 in transitional cell carcinoma of the urinary bladder with regional lymph node involvement.
Cancer 2004;101(8):1803-8.
2004: David S DiMarco; Christine M Lohse; Horst Zincke; John C Cheville; Michael L Blute
Long-term survival of patients with unilateral sporadic multifocal renal cell carcinoma according to histologic subtype compared with patients with solitary tumors after radical nephrectomy.
Urology 2004;64(3):462-7.
2004: Michael L Blute; Bradley C Leibovich; John C Cheville; Christine M Lohse; Horst Zincke
A protocol for performing extended lymph node dissection using primary tumor pathological features for patients treated with radical nephrectomy for clear cell renal cell carcinoma.
The Journal of urology 2004;172(2):465-9.
2004: Michael L Blute; Bradley C Leibovich; Christine M Lohse; John C Cheville; Horst Zincke
The Mayo Clinic experience with surgical management, complications and outcome for patients with renal cell carcinoma and venous tumour thrombus.
BJU international 2004;94(1):33-41.
2004: Alexander S Parker; John C Cheville; Michael L Blute; Todd C Igel; Christine M Lohse; James Cerhan
Pathologic T1 clear cell renal cell carcinoma: insulin-like growth factor-I receptor expression and disease-specific survival.
Cancer 2004;100(12):2577-82.
2004: John C Cheville; Christine M Lohse; Horst Zincke; Amy L Weaver; Bradley C Leibovich; Igor Frank; Michael L Blute
Sarcomatoid renal cell carcinoma: an examination of underlying histologic subtype and an analysis of associations with patient outcome.
The American journal of surgical pathology 2004;28(4):435-41.
2004: Bradley C Leibovich; Michael L Blute; John C Cheville; Christine M Lohse; Amy L Weaver; Horst Zincke
Nephron sparing surgery for appropriately selected renal cell carcinoma between 4 and 7 cm results in outcome similar to radical nephrectomy.
The Journal of urology 2004;171(3):1066-70.
2004: Schuyler O Sanderson; Thomas J Sebo; Linda M Murphy; Roxann Neumann; Jeff Slezak; John C Cheville
An analysis of the p63/alpha-methylacyl coenzyme A racemase immunohistochemical cocktail stain in prostate needle biopsy specimens and tissue microarrays.
American journal of clinical pathology 2004;121(2):220-5.
2003: Igor Frank; Michael L Blute; John C Cheville; Christine M Lohse; Amy L Weaver; Bradley C Leibovich; Horst Zincke
A multifactorial postoperative surveillance model for patients with surgically treated clear cell renal cell carcinoma.
The Journal of urology 2003;170(6 Pt 1):2225-32.
2003: Igor Frank; Michael L Blute; John C Cheville; Christine M Lohse; Amy L Weaver; Horst Zincke
Solid renal tumors: an analysis of pathological features related to tumor size.
The Journal of urology 2003;170(6 Pt 1):2217-20.
2003: David S DiMarco; Michael L Blute; Horst Zincke; John C Cheville; Darren L Riehle; Christine M Lohse; V Shane Pankratz; Thomas J Sebo
Multivariate models to predict clinically important outcomes at prostatectomy for patients with organ-confined disease and needle biopsy Gleason scores of 6 or less.
Urologic oncology 2003;21(6):439-46.
2003: Kent G Krejci; Michael L Blute; John C Cheville; Thomas J Sebo; Christine M Lohse; Horst Zincke
Nephron-sparing surgery for renal cell carcinoma: clinicopathologic features predictive of patient outcome.
Urology 2003;62(4):641-6.
2003: Donkena Krishna Vanaja; John C Cheville; Steve J Iturria; Charles Y F Young
Transcriptional silencing of zinc finger protein 185 identified by expression profiling is associated with prostate cancer progression.
Cancer research 2003;63(14):3877-82.
2003: Weber K Lau; Horst Zincke; Christine M Lohse; John C Cheville; Amy L Weaver; Michael L Blute
Contralateral adrenal metastasis of renal cell carcinoma: treatment, outcome and a review.
BJU international 2003;91(9):775-9.
2003: Igor Frank; John C Cheville; Michael L Blute; Christine M Lohse; Ajay Nehra; Amy L Weaver; R Jeffrey Karnes; Horst Zincke
Transitional cell carcinoma of the urinary bladder with regional lymph node involvement treated by cystectomy: clinicopathologic features associated with outcome.
Cancer 2003;97(10):2425-31.
2003: John C Cheville; Christine M Lohse; Horst Zincke; Amy L Weaver; Michael L Blute
Comparisons of outcome and prognostic features among histologic subtypes of renal cell carcinoma.
The American journal of surgical pathology 2003;27(5):612-24.
2003: Bradley C Leibovich; Michael L Blute; John C Cheville; Christine M Lohse; Igor Frank; Eugene D Kwon; Amy L Weaver; Alexander S Parker; Horst Zincke
Prediction of progression after radical nephrectomy for patients with clear cell renal cell carcinoma: a stratification tool for prospective clinical trials.
Cancer 2003;97(7):1663-71.
2003: Michael L Blute; Nancy B Itano; John C Cheville; Amy L Weaver; Christine M Lohse; Horst Zincke
The effect of bilaterality, pathological features and surgical outcome in nonhereditary renal cell carcinoma.
The Journal of urology 2003;169(4):1276-81.
2003: Arndt Hartmann; Wolfgang Dietmaier; Ferdinand Hofstädter; Lawrence J Burgart; John C Cheville; Hagen Blaszyk
Urothelial carcinoma of the upper urinary tract: inverted growth pattern is predictive of microsatellite instability.
Human pathology 2003;34(3):222-7.
2003: Phillip A Isotalo; Antonio G Nascimento; Victor F Trastek; Lester E Wold; John C Cheville
Extragenital adenomatoid tumor of a mediastinal lymph node.
Mayo Clinic proceedings. Mayo Clinic 2003;78(3):350-4.
2003: Xiangyang Dong; Liang Wang; Ken Taniguchi; Xianshu Wang; Julie M Cunningham; Shannon K McDonnell; Chiping Qian; Angela F Marks; Susan L Slager; Brett J Peterson; David I Smith; John C Cheville; Michael L Blute; Steve J Jacobsen; Daniel J Schaid; Donald J Tindall; Stephen N Thibodeau; Wanguo Liu
Mutations in CHEK2 associated with prostate cancer risk.
American journal of human genetics 2003;72(2):270-80.
2002: Igor Frank; Michael L Blute; John C Cheville; Christine M Lohse; Amy L Weaver; Horst Zincke
An outcome prediction model for patients with clear cell renal cell carcinoma treated with radical nephrectomy based on tumor stage, size, grade and necrosis: the SSIGN score.
The Journal of urology 2002;168(6):2395-400.
2002: Farhad Kosari; Yan W Asmann; John C Cheville; George Vasmatzis
Cysteine-rich secretory protein-3: a potential biomarker for prostate cancer.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2002;11(11):1419-26.
2002: John C Cheville; Donald Tindall; Christopher Boelter; Robert Jenkins; Christine M Lohse; V Shane Pankratz; Thomas J Sebo; Brian Davis; Michael L Blute
Metastatic prostate carcinoma to bone: clinical and pathologic features associated with cancer-specific survival.
Cancer 2002;95(5):1028-36.
2002: Hagen Blaszyk; Linan Wang; Wolfgang Dietmaier; Ferdinand Hofstädter; Lawrence J Burgart; John C Cheville; Arndt Hartmann
Upper tract urothelial carcinoma: a clinicopathologic study including microsatellite instability analysis.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2002;15(8):790-7.
2002: Yan W Asmann; Farhad Kosari; Kai Wang; John C Cheville; George Vasmatzis
Identification of differentially expressed genes in normal and malignant prostate by electronic profiling of expressed sequence tags.
Cancer research 2002;62(11):3308-14.
2002: Kevin C Halling; Walter King; Irina A Sokolova; R Jeffrey Karnes; Reid G Meyer; Eric L Powell; Thomas J Sebo; John C Cheville; Amy C Clayton; Kelly L Krajnik; Thomas A Ebert; Robert E Nelson; Haleh M Burkhardt; Sanjay Ramakumar; Christopher S Stewart; V Shane Pankratz; Michael M Lieber; Michael L Blute; Horst Zincke; Steven A Seelig; Robert B Jenkins; Dennis J O'Kane
A comparison of BTA stat, hemoglobin dipstick, telomerase and Vysis UroVysion assays for the detection of urothelial carcinoma in urine.
The Journal of urology 2002;167(5):2001-6.
2002: Weber K Lau; John C Cheville; Michael L Blute; Amy L Weaver; Horst Zincke
Prognostic features of pathologic stage T1 renal cell carcinoma after radical nephrectomy.
Urology 2002;59(4):532-7.
2002: Thomas J Sebo; John C Cheville; Darren L Riehle; Christine M Lohse; V Shane Pankratz; Robert P Myers; Michael L Blute; Horst Zincke
Perineural invasion and MIB-1 positivity in addition to Gleason score are significant preoperative predictors of progression after radical retropubic prostatectomy for prostate cancer.
The American journal of surgical pathology 2002;26(4):431-9.
2002: Paul A Kay; Darren L Riehle; John C Cheville; Christine M Lohse; V Shane Pankratz; Eunice M Hill; Thomas J Sebo
Comparison of quantitative histomorphometry and DNA ploidy in tissue sections of prostate carcinoma.
Analytical and quantitative cytology and histology / the International Academy of Cytology [and] American Society of Cytology 2002;24(1):7-14.
2001: T E Muir; John C Cheville; Donna J Lager
Metanephric adenoma, nephrogenic rests, and Wilms' tumor: a histologic and immunophenotypic comparison.
The American journal of surgical pathology 2001;25(10):1290-6.
2001: Thomas J Sebo; John C Cheville; Darren L Riehle; Christine M Lohse; V Shane Pankratz; Robert P Myers; Michael L Blute; Horst Zincke
Predicting prostate carcinoma volume and stage at radical prostatectomy by assessing needle biopsy specimens for percent surface area and cores positive for carcinoma, perineural invasion, Gleason score, DNA ploidy and proliferation, and preoperative serum prostate specific antigen: a report of 454 cases.
Cancer 2001;91(11):2196-204.
2001: Rebecca F McClure; Gary L Keeney; Thomas J Sebo; John C Cheville
Serous borderline tumor of the paratestis: a report of seven cases.
The American journal of surgical pathology 2001;25(3):373-8.
2000: Kevin C Halling; Walter King; Irina A Sokolova; Reid G Meyer; Haleh M Burkhardt; A C Halling; John C Cheville; Thomas J Sebo; Sanjay Ramakumar; Christopher S Stewart; S Pankratz; Dennis J O'Kane; Steven A Seelig; Michael M Lieber; Robert B Jenkins
A comparison of cytology and fluorescence in situ hybridization for the detection of urothelial carcinoma.
The Journal of urology 2000;164(5):1768-75.
2000: Thomas M Pisansky; Timothy F Kozelsky; Robert P Myers; D W Hillman; Michael L Blute; Steven J. Buskirk; John C Cheville; Robert G Ferrigni; Steven E Schild
Radiotherapy for isolated serum prostate specific antigen elevation after prostatectomy for prostate cancer.
The Journal of urology 2000;163(3):845-50.
2000: Thomas J Sebo; B J Bock; John C Cheville; Christine M Lohse; P Wollan; Horst Zincke
The percent of cores positive for cancer in prostate needle biopsy specimens is strongly predictive of tumor stage and volume at radical prostatectomy.
The Journal of urology 2000;163(1):174-8.
1998: Kenneth A Iczkowski; David G Bostwick; Patrick C Roche; John C Cheville
Inhibin A is a sensitive and specific marker for testicular sex cord-stromal tumors.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 1998;11(8):774-9.